Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech firesales -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (2638)	2/16/2011 3:45:50 PM
From: tuck	Read Replies (1) \| Respond to of 3661

>>"Speaking of recent financing, DSCO off 23% on another one. Is it enough to get them over the finish line, meaning the sell-off is a buying op? Probably no rush, as potential approval is a good year away . . ." Message 26624274 Today off 31% on ANOTHER crappy financing, so I guess that answers my question. Maybe now?<< This time the stock is off 28%, below the price of the units, but of course, the units have warrants attached. They are posturing for potential approval in Q1 2012. For that to happen, they'll need to file the Complete Response within six months, and the FDA obviously has to go for it. Certainly a better buying op than the last one . . . Cheers, Tuck